A new study published in Otolaryngology–Head and Neck Surgery reveals that glucagon-like peptide-1 receptor agonists ...
A new Australian study has found that a simple saline nasal spray could help many children breathe and sleep better, ...
What starts as a minor inconvenience can snowball into chronic sinusitis, recurrent infections, and even more serious ENT ...
Tianjin Tianyao Pharmaceuticals Co. Ltd. has identified glucocorticoid receptor (GR) agonists reported to be useful for the treatment of conjunctivitis, asthma, chronic obstructive pulmonary disease, ...
A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...
GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...
GSK on Tuesday said Japan’s Ministry of Health, Labour and Welfare approved Exdensur, also known as depemokimab, for patients with bronchial asthma whose symptoms cannot be controlled with existing ...
Angela Read will never again be able to smell freshly cut grass or cigar smoke on a golf course. She mourns the loss of these small pleasures, but resists falling into cynicism. “I don’t get myself ...
Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback